How big is the eye disease market?
According to 绿帽社 internal database and industry insights, the eye disease market was valued at approximately USD 42.6 billion in 2024 and is projected to reach USD 61.3 billion by 2031, growing at a CAGR of 5.3% during the forecast period.
This growth is driven by the aging worldwide population, increasing prevalence of diabetes-related eye conditions, and advancements in diagnostic and treatment technologies. The sector is also witnessing increased R&D investment in gene editing technologies for inherited retinal disorders.
Key Growth Factors of the Eye Disease Market
- Rising geriatric population prone to conditions like cataracts, AMD, and glaucoma
- Increasing incidence of diabetes boosting demand for diabetic retinopathy treatments
- Advancements in gene therapy, retinal implants, and biologics for degenerative diseases
- Growing awareness about early screening and routine eye check-ups
- Government initiatives supporting eye health programs and ophthalmology infrastructure
- Technological integration in diagnostics such as AI-based retinal imaging systems
Eye Disease Market Trends
The market is shifting toward personalized medicine and targeted therapies. There is growing interest in minimally invasive surgeries and sustained-release drug delivery systems. Teleophthalmology is gaining traction in rural and underserved regions. Artificial intelligence and machine learning are transforming eye disease diagnostics with real-time imaging and predictive analysis.
Emerging Developments in the Eye Disease Market
Emerging developments in the eye disease market include pharmaceutical and biotech companies are actively investing in regenerative therapies and stem cell research for retinal repair. Novel drug delivery devices such as ocular implants and eye drop with improved bioavailability are entering the market. AI-driven screening platforms are being introduced in community health centers. Collaborative efforts between tech firms and medical institutions are driving innovation in cloud-based patient management and diagnostics for eye care.
Leading Companies in the Eye Disease Market
- Novartis AG
- Regeneron Pharmaceuticals, Inc.
- Genentech, Inc. (Roche)
- Allergan (AbbVie Inc.)
- Bayer AG
- Alcon Inc.
How Big Is the Eye Disease Market : FAQ's
The eye disease market is projected to reach USD 61.3 billion by 2031.
The retinal disease segment, particularly age-related macular degeneration, is growing rapidly due to aging demographics.
The challenges are high treatment costs, low accessibility in rural areas, and regulatory delays.
Key drivers include the increasing prevalence of eye disorders, growing awareness of early diagnosis, technological advancements.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com